As TRAIL-DR4 signaling initiates caspase-8-dependent apoptosis (8), we first detected the activation of caspase-8 in HCC cells treated with anti-miR-106b and TRAIL. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.